Record Revenue of $130.7 million in the
Third Quarter
Record Network Revenue of $22.6 million; an
87% YoY increase
GAAP Earnings Per Share of $0.31; Non-GAAP
Earnings Per Share of $0.51
Proto Labs, Inc. ("Protolabs" or the "Company") (NYSE: PRLB),
the world’s leading provider of digital manufacturing services,
today announced financial results for the third quarter ended
September 30, 2023.
Third Quarter 2023 Highlights:
- Revenue for the third quarter of 2023 was a record $130.7
million, representing a 7.4% increase over the third quarter of
2022.
- Revenue generated from the digital network, powered by Hubs,
was $22.6 million in the third quarter, representing growth of
86.9% over the third quarter of the prior year.
- Net income for the third quarter of 2023 was $8.0 million, or
$0.31 per diluted share.
- Non-GAAP net income was $13.2 million, or $0.51 per diluted
share. See “Non-GAAP Financial Measures” below.
"Protolabs produced third quarter financial results that
surpassed our expectations on the top and bottom line. We generated
record revenue, improved profitability, generated substantial cash
flow, and returned capital to shareholders." said Rob Bodor,
President and Chief Executive Officer. "This excellent financial
performance demonstrates the success of our strategy; Protolabs'
unique hybrid model combining the digital factory and the digital
network is the best way to grow profitably in our industry. We
experienced increased demand for our comprehensive
digitally-enabled manufacturing capabilities in the quarter. The
model is winning and customers are delighted."
Additional Third Quarter 2023
Highlights:
- Protolabs served 23,080 unique product developers during the
quarter.
- Gross margin was 45.4% in the third quarter of 2023, up
sequentially from 43.4% in the second quarter of 2023.
- Non-GAAP gross margin was 46.0% in the third quarter of 2023,
representing a sequential increase of 190 basis points. See
“Non-GAAP Financial Measures” below.
- EBITDA was $19.5 million, or 14.9% of revenue, in the third
quarter of 2023, compared to $11.4 million, or 9.3% of revenue, in
the second quarter of 2023. See “Non-GAAP Financial Measures”
below.
- Adjusted EBITDA was $23.9 million, or 18.3% of revenue, in the
third quarter of 2023, compared to $19.2 million, or 15.7% of
revenue, in the second quarter of 2023. See “Non-GAAP Financial
Measures” below.
- Cash flow from operations was $24.2 million in the third
quarter of 2023, compared to $9.3 million in the second quarter of
2023.
- The Company repurchased $9.0 million of shares during the
quarter.
- Cash and investments balance was $114.9 million as of September
30, 2023.
"Along with record revenue in the third quarter, we made
substantial progress on our priority to improve profitability in
both the digital factory and the digital network," said Dan
Schumacher, Chief Financial Officer. "Through a challenging macro
environment, Protolabs has demonstrated the industry-leading
earnings power and cash flow generation of our business model,
enabling us to continue to invest in future growth and return
capital to shareholders."
Non-GAAP Financial Measures
The Company has included non-GAAP revenue growth by region and
by service line that excludes the impact of changes in foreign
currency exchange rates (collectively, “non-GAAP revenue growth”).
Management believes these metrics, when viewed in conjunction with
the comparable GAAP metrics, are useful in evaluating the
underlying business trends and ongoing operating performance of the
Company.
The Company has included earnings before interest, taxes,
depreciation and amortization (“EBITDA”) and EBITDA, adjusted for
stock-based compensation expense, unrealized (gain) loss on foreign
currency and costs related to the Japan closure activities
(collectively, “Adjusted EBITDA”), in this press release to provide
investors with additional information regarding the Company’s
financial results. The Company has also included earnings before
interest, taxes, depreciation and amortization margin (“EBITDA
margin”) and EBITDA margin, adjusted for stock-based compensation
expense, unrealized (gain) loss on foreign currency and costs
related to the Japan closure activities (collectively, “Adjusted
EBITDA margin”), in this press release to provide investors with
additional information regarding the Company’s financial
results.
The Company has included non-GAAP gross margin, adjusted for
stock-based compensation expense and amortization expense in this
press release to provide investors with additional information
regarding the Company’s financial results.
The Company has included non-GAAP operating margin, adjusted for
stock-based compensation expense, amortization expense and costs
related to the closure of Japan (collectively, “non-GAAP operating
margin”), in this press release to provide investors with
additional information regarding the Company’s financial
results.
The Company has included non-GAAP gross margin excluding Japan,
adjusted for stock-based compensation expense and amortization
expense in this press release to provide investors with additional
information regarding the Company’s financial results. The Company
has included non-GAAP operating margin excluding Japan, adjusted
for stock-based compensation expense, amortization expense, and
costs related to the Japan closure activities (collectively,
“non-GAAP operating margin excluding Japan”), in this press release
to provide investors with additional information regarding the
Company’s financial results.
The Company has included non-GAAP net income, adjusted for
stock-based compensation expense, amortization expense, unrealized
(gain) loss on foreign currency and costs related to the closure of
Japan (collectively, “non-GAAP net income”), in this press release
to provide investors with additional information regarding the
Company’s financial results.
The Company has provided below reconciliations of GAAP to
non-GAAP net income, non-GAAP gross margin, non-GAAP gross margin
excluding Japan, non-GAAP operating margin, non-GAAP operating
margin excluding Japan, non-GAAP revenue growth by region and by
service, and Adjusted EBITDA and Adjusted EBITDA margin, the most
directly comparable measures calculated and presented in accordance
with GAAP. These non-GAAP measures are used by the Company’s
management and board of directors to understand and evaluate
operating performance and trends and provide useful measures for
period-to-period comparisons of the Company’s business.
Accordingly, the Company believes that these non-GAAP measures
provide useful information to investors and others in understanding
and evaluating operating results in the same manner as our
management and board of directors.
Conference Call
The Company has scheduled a conference call to discuss its third
quarter 2023 financial results and fourth quarter 2023 outlook
today, November 3, 2023 at 8:30 a.m. EDT. To access the call in the
U.S. please dial 877-709-8150 or outside the U.S. dial 201-689-8354
at least five minutes prior to the 8:30 a.m. EDT start time. No
participant code is required. A simultaneous webcast of the call
and accompanying presentation will be available via the investor
relations section of the Protolabs website and the following link:
https://edge.media-server.com/mmc/p/ic4eziw6. A replay will be
available for 14 days following the call on the investor relations
section of the Protolabs website.
About Protolabs
Protolabs is the fastest and most comprehensive digital
manufacturing service in the world. Our digital factories produce
low-volume parts in days while our digital network of manufacturing
partners powered by Hubs unlocks advanced capabilities and volume
pricing at higher quantities. The result? One manufacturing
source—from prototyping to production—for product developers,
engineers, and supply chain teams across the globe. See what's next
at protolabs.com.
Forward-Looking Statements
Statements contained in this press release regarding matters
that are not historical or current facts are “forward-looking
statements” within the meaning of The Private Securities Litigation
Reform Act of 1995. These statements involve known and unknown
risks, uncertainties and other factors which may cause the results
of Protolabs to be materially different than those expressed or
implied in such statements. Certain of these risk factors and
others are described in the “Risk Factors” section within reports
filed with the SEC. Other unknown or unpredictable factors also
could have material adverse effects on Protolabs’ future results.
The forward-looking statements included in this press release are
made only as of the date hereof. Protolabs cannot guarantee future
results, levels of activity, performance or achievements.
Accordingly, you should not place undue reliance on these
forward-looking statements. Finally, Protolabs expressly disclaims
any intent or obligation to update any forward-looking statements
to reflect subsequent events or circumstances.
Proto Labs, Inc.
Condensed Consolidated Balance
Sheets
(In thousands)
September 30,
2023
December 31,
2022
(Unaudited)
Assets
Current assets
Cash and cash equivalents
$
83,496
$
56,558
Short-term marketable securities
19,204
23,568
Accounts receivable, net
78,395
76,225
Inventory
13,803
13,578
Income taxes receivable
891
4,042
Prepaid expenses and other current
assets
8,722
12,597
Total current assets
204,511
186,568
Property and equipment, net
243,022
257,785
Goodwill
273,991
273,991
Other intangible assets, net
26,668
31,250
Long-term marketable securities
12,212
26,419
Operating lease assets
2,737
3,844
Finance lease assets
16,763
17,532
Other long-term assets
4,341
4,779
Total assets
$
784,245
$
802,168
Liabilities and shareholders'
equity
Current liabilities
Accounts payable
$
17,922
$
17,356
Accrued compensation
16,337
12,743
Accrued liabilities and other
21,027
22,384
Current operating lease liabilities
1,568
1,561
Current finance lease liabilities
16,630
17,537
Income taxes payable
1,144
—
Total current liabilities
74,628
71,581
Long-term operating lease liabilities
1,545
2,255
Long-term finance lease liabilities
671
—
Long-term deferred tax liabilities
17,138
26,322
Other long-term liabilities
5,341
4,362
Shareholders' equity
684,922
697,648
Total liabilities and shareholders'
equity
$
784,245
$
802,168
Proto Labs, Inc.
Condensed Consolidated
Statements of Operations
(In thousands, except share
and per share amounts)
(Unaudited)
Three Months Ended
September 30,
Nine Months Ended
September 30,
2023
2022
2023
2022
Revenue
Injection Molding
$
51,688
$
48,940
$
152,455
$
155,693
CNC Machining
52,916
47,489
149,317
141,809
3D Printing
21,622
19,823
63,952
59,458
Sheet Metal
4,291
5,219
12,478
15,066
Other Revenue
188
250
627
765
Total Revenue
130,705
121,721
378,829
372,791
Cost of revenue
71,423
68,089
212,648
205,933
Gross profit
59,282
53,632
166,181
166,858
Operating expenses
Marketing and sales
21,682
20,594
65,863
62,235
Research and development
10,105
9,309
30,647
29,316
General and administrative
17,058
16,477
49,713
49,770
Closure of Japan business
22
1,194
186
6,388
Total operating expenses
48,867
47,574
146,409
147,709
Income from operations
10,415
6,058
19,772
19,149
Other income (loss), net
320
(24
)
(1,758
)
(323
)
Income before income taxes
10,735
6,034
18,014
18,826
Provision for income taxes
2,781
2,083
7,784
7,223
Net income
$
7,954
$
3,951
$
10,230
$
11,603
Net income per share:
Basic
$
0.31
$
0.14
$
0.39
$
0.42
Diluted
$
0.31
$
0.14
$
0.39
$
0.42
Shares used to compute net income per
share:
Basic
26,023,830
27,505,097
26,296,304
27,512,057
Diluted
26,028,456
27,508,217
26,327,606
27,522,734
Proto Labs, Inc.
Condensed Consolidated
Statements of Cash Flows
(In thousands)
(Unaudited)
Nine Months Ended
September 30,
2023
2022
Operating activities
Net income
$
10,230
$
11,603
Adjustments to reconcile net income to net
cash provided by operating activities:
Depreciation and amortization
28,213
29,981
Stock-based compensation expense
11,811
13,335
Deferred taxes
(9,197
)
(8,920
)
Interest on finance lease obligations
859
-
Loss on foreign currency translation
3,906
-
Impairments related to closure of Japan
business
-
2,842
Gain on disposal of property and
equipment
(498
)
(1,174
)
Other
122
11
Changes in operating assets and
liabilities:
10,600
3,886
Net cash provided by operating
activities
56,046
51,564
Investing activities
Purchases of property, equipment and other
capital assets
(9,935
)
(16,414
)
Proceeds from sales of property, equipment
and other capital assets
693
3,227
Purchases of marketable securities
-
(45,872
)
Proceeds from sales of marketable
securities
-
1,998
Proceeds from call redemptions and
maturities of marketable securities
19,115
13,696
Net cash provided by (used in) investing
activities
9,873
(43,365
)
Financing activities
Proceeds from exercises of stock
options
1,986
2,311
Purchases of shares withheld for tax
obligations
(1,436
)
(1,615
)
Repurchases of common stock
(39,053
)
(13,074
)
Principal repayments of finance lease
obligations
(234
)
(417
)
Net cash used in financing activities
(38,737
)
(12,795
)
Effect of exchange rate changes on cash
and cash equivalents
(244
)
(1,972
)
Net increase (decrease) in cash and
cash equivalents
26,938
(6,568
)
Cash and cash equivalents, beginning of
period
56,558
65,929
Cash and cash equivalents, end of
period
$
83,496
$
59,361
Proto Labs, Inc.
Reconciliation of GAAP to
Non-GAAP Net Income per Share
(In thousands, except share
and per share amounts)
(Unaudited)
Three Months Ended
September 30,
Nine Months Ended
September 30,
2023
2022
2023
2022
Non-GAAP net income, adjusted for
stock-based compensation expense, amortization expense, unrealized
(gain) loss on foreign currency and costs related to Japan closure
activities
GAAP net income
$
7,954
$
3,951
$
10,230
$
11,603
Add back:
Stock-based compensation expense
4,441
4,907
11,811
13,335
Amortization expense
1,461
1,510
4,471
4,582
Unrealized (gain) loss on foreign
currency
(29
)
382
86
742
Costs related to Japan closure
activities
22
1,194
4,093
6,388
Total adjustments 1
5,895
7,993
20,461
25,047
Income tax benefits on adjustments 2
(633
)
(1,060
)
(931
)
(2,518
)
Non-GAAP net income
$
13,216
$
10,884
$
29,760
$
34,132
Non-GAAP net income per share:
Basic
$
0.51
$
0.40
$
1.13
$
1.24
Diluted
$
0.51
$
0.40
$
1.13
$
1.24
Shares used to compute non-GAAP net income
per share:
Basic
26,023,830
27,505,097
26,296,304
27,512,057
Diluted
26,028,456
27,508,217
26,327,606
27,522,734
1
Stock-based compensation expense,
amortization expense, unrealized (gain) loss on foreign currency
and costs related to Japan closure activities were included in the
following GAAP consolidated statement of operations categories:
Three Months Ended
September 30,
Nine Months Ended
September 30,
2023
2022
2023
2022
Cost of revenue
$
805
$
902
$
2,416
$
2,701
Marketing and sales
961
929
2,508
2,479
Research and development
675
602
1,888
1,702
General and administrative
3,461
3,984
9,471
11,035
Closure of Japan business
22
1,194
186
6,388
Total operating expenses
5,119
6,709
14,053
21,604
Other income (loss), net
(29
)
382
3,992
742
Total adjustments
$
5,895
$
7,993
$
20,461
$
25,047
2
For the three and nine months ended
September 30, 2023 and 2022, income tax effects were calculated
using the effective tax rate for the relevant jurisdictions. The
Company's non-GAAP tax rates differ from its GAAP tax rates due
primarily to the mix of activity incurred in domestic and foreign
tax jurisdictions and removing effective tax rate benefits from
stock-based compensation activity in the quarter.
Proto Labs, Inc.
Reconciliation of GAAP to
Non-GAAP Gross Margin
(In thousands)
(Unaudited)
Three Months Ended
September 30,
Nine Months Ended
September 30,
2023
2022
2023
2022
Revenue
$
130,705
$
121,721
$
378,829
$
372,791
Gross profit
59,282
53,632
166,181
166,858
GAAP gross margin
45.4
%
44.1
%
43.9
%
44.8
%
Add back:
Stock-based compensation expense
462
560
1,388
1,674
Amortization expense
343
342
1,028
1,027
Total adjustments
805
902
2,416
2,701
Non-GAAP gross profit
$
60,087
$
54,534
$
168,597
$
169,559
Non-GAAP gross margin
46.0
%
44.8
%
44.5
%
45.5
%
Proto Labs, Inc.
Reconciliation of GAAP to
Non-GAAP Gross Margin Excluding Japan
(In thousands)
(Unaudited)
Three Months Ended
September 30,
Nine Months Ended
September 30,
2023
2022
2023
2022
Revenue
$
130,705
$
121,721
$
378,829
$
372,791
Revenue excluding Japan
$
130,705
$
120,434
$
378,829
$
364,562
Gross profit
59,282
53,632
166,181
166,858
GAAP gross margin
45.4
%
44.1
%
43.9
%
44.8
%
Less: Japan gross profit
-
47
-
3,150
Gross Profit excluding Japan
59,282
53,585
166,181
163,708
GAAP gross margin excluding Japan
45.4
%
44.5
%
43.9
%
44.9
%
Add back:
Stock-based compensation expense
462
560
1,388
1,674
Amortization expense
343
342
1,028
1,027
Less:
Japan stock-based compensation expense
-
13
-
61
Japan amortization expense
-
-
-
-
Total adjustments
805
889
2,416
2,640
Non-GAAP gross profit excluding Japan
$
60,087
$
54,474
$
168,597
$
166,348
Non-GAAP gross margin excluding Japan
46.0
%
45.2
%
44.5
%
45.6
%
Proto Labs, Inc.
Reconciliation of GAAP to
Non-GAAP Operating Margin
(In thousands)
(Unaudited)
Three Months Ended
September 30,
Nine Months Ended
September 30,
2023
2022
2023
2022
Revenue
$
130,705
$
121,721
$
378,829
$
372,791
Income from operations
10,415
6,058
19,772
19,149
GAAP operating margin
8.0
%
5.0
%
5.2
%
5.1
%
Add back:
Stock-based compensation expense
4,441
4,907
11,811
13,335
Amortization expense
1,461
1,510
4,471
4,582
Costs related to Japan closure
activities
22
1,194
186
6,388
Total adjustments
5,924
7,611
16,468
24,305
Non-GAAP income from operations
$
16,339
$
13,669
$
36,240
$
43,454
Non-GAAP operating margin
12.5
%
11.2
%
9.6
%
11.7
%
Proto Labs, Inc.
Reconciliation of GAAP to
Non-GAAP Operating Margin Excluding Japan
(In thousands)
(Unaudited)
Three Months Ended
September 30,
Nine Months Ended
September 30,
2023
2022
2023
2022
Revenue
$
130,705
$
121,721
$
378,829
$
372,791
Revenue excluding Japan
$
130,705
$
120,434
$
378,829
$
364,562
Income from operations
10,415
6,058
19,772
19,149
GAAP operating margin
8.0
%
5.0
%
5.2
%
5.1
%
Less: Japan (loss) income from
operations
(7
)
(724
)
(481
)
(720
)
Income from operations excluding Japan
10,422
6,782
20,253
19,869
GAAP operating margin excluding Japan
8.0
%
5.6
%
5.3
%
5.5
%
Add back:
Stock-based compensation expense
4,441
4,907
11,811
13,335
Amortization expense
1,461
1,510
4,471
4,582
Costs related to Japan closure
activities
22
1,194
186
6,388
Less:
Japan stock-based compensation expense
-
89
17
386
Japan amortization expense
-
-
-
-
Total adjustments
5,924
7,522
16,451
23,919
Non-GAAP income from operations excluding
Japan
$
16,346
$
14,304
$
36,704
$
43,788
Non-GAAP operating margin excluding
Japan
12.5
%
11.9
%
9.7
%
12.0
%
Proto Labs, Inc.
Reconciliation of GAAP Net
Income to EBITDA and Adjusted EBITDA
(In thousands)
(Unaudited)
Three Months Ended
September 30,
Nine Months Ended
September 30,
2023
2022
2023
2022
Revenue
$
130,705
$
121,721
$
378,829
$
372,791
GAAP net income
7,954
3,951
10,230
11,603
GAAP net income margin
6.1
%
3.2
%
2.7
%
3.1
%
Add back:
Amortization expense
$
1,461
$
1,510
$
4,471
$
4,582
Depreciation expense
7,869
8,197
23,742
25,399
Interest income, net
(561
)
(265
)
(1,283
)
(459
)
Provision for income taxes
2,781
2,083
7,784
7,223
EBITDA
19,504
15,476
44,944
48,348
EBITDA Margin
14.9
%
12.7
%
11.9
%
13.0
%
Add back:
Stock-based compensation expense
4,441
4,907
11,811
13,335
Unrealized (gain) loss on foreign
currency
(29
)
382
86
742
Costs related to Japan closure
activities
22
1,194
4,093
6,388
Total adjustments
4,434
6,483
15,990
20,465
Adjusted EBITDA
$
23,938
$
21,959
$
60,934
$
68,813
Adjusted EBITDA Margin
18.3
%
18.0
%
16.1
%
18.5
%
Proto Labs, Inc.
Comparison of GAAP to Non-GAAP
Revenue Growth by Region
(In thousands)
(Unaudited)
Three Months Ended
September 30, 2023
Three Months Ended September
30, 2022
%
Change2
% Change
Organic3
GAAP
Foreign
Currency1
Non-GAAP
GAAP
Revenues
United States
$
103,940
$
-
$
103,940
$
98,970
5.0
%
5.0
%
Europe
26,765
(1,666
)
25,099
21,464
24.7
%
16.9
%
Japan
-
-
-
1,287
(100.0
%)
(100.0
%)
Total revenue
$
130,705
$
(1,666
)
$
129,039
$
121,721
7.4
%
6.0
%
Nine Months Ended
September 30, 2023
Nine Months Ended September
30, 2022
%
Change2
% Change
Organic3
GAAP
Foreign
Currency1
Non-GAAP
GAAP
Revenues
United States
$
298,007
$
-
$
298,007
$
295,121
1.0
%
1.0
%
Europe
80,822
1,311
82,133
69,441
16.4
%
18.3
%
Japan
-
-
-
8,229
(100.0
%)
(100.0
%)
Total revenue
$
378,829
$
1,311
$
380,140
$
372,791
1.6
%
2.0
%
1
Revenue for the three and nine months
ended September 30, 2023 has been recalculated using 2022 foreign
currency exchange rates in effect during comparable periods to
provide information useful in evaluating the underlying business
trends excluding the impact of changes in foreign currency exchange
rates.
2
This column presents the percentage change
from GAAP revenue for the three and nine months ended September 30,
2022 to GAAP revenue for the three and nine months ended September
30, 2023.
3
This column presents the percentage change
from GAAP revenue for the three and nine months ended September 30,
2022 to non-GAAP revenue for the three and nine months ended
September 30, 2023 (as recalculated using the foreign currency
exchange rates in effect during the three and nine months ended
September 30, 2022) in order to provide a constant-currency
comparison.
Proto Labs, Inc.
Comparison of GAAP to Non-GAAP
Revenue Growth by Service Line
(In thousands)
(Unaudited)
Three Months Ended
September 30, 2023
Three Months Ended
September 30, 2022
%
Change2
% Change
Organic3
GAAP
Foreign
Currency1
Non-GAAP
GAAP
Revenues
Injection Molding
$
51,688
$
(655
)
$
51,033
$
48,940
5.6
%
4.3
%
CNC Machining
52,916
(708
)
52,208
47,489
11.4
9.9
3D Printing
21,622
(390
)
21,232
19,823
9.1
7.1
Sheet Metal
4,291
(20
)
4,271
5,219
(17.8
)
(18.2
)
Other Revenue
188
107
295
250
(24.8
)
18.0
Total Revenue
$
130,705
$
(1,666
)
$
129,039
$
121,721
7.4
%
6.0
%
Nine Months Ended
September 30, 2023
Nine Months Ended September
30, 2022
%
Change2
% Change
Organic3
GAAP
Foreign
Currency1
Non-GAAP
GAAP
Revenues
Injection Molding
$
152,455
$
781
$
153,236
$
155,693
(2.1
)%
(1.6
)%
CNC Machining
149,317
152
149,469
141,809
5.3
5.4
3D Printing
63,952
277
64,229
59,458
7.6
8.0
Sheet Metal
12,478
(9
)
12,469
15,066
(17.2
)
(17.2
)
Other Revenue
627
110
737
765
(18.0
)
(3.7
)
Total Revenue
$
378,829
$
1,311
$
380,140
$
372,791
1.6
%
2.0
%
1
Revenue for the three and nine months
ended September 30, 2023 has been recalculated using 2022 foreign
currency exchange rates in effect during comparable periods to
provide information useful in evaluating the underlying business
trends excluding the impact of changes in foreign currency exchange
rates.
2
This column presents the percentage change
from GAAP revenue for the three and nine months ended September 30,
2022 to GAAP revenue for the three and nine months ended September
30, 2023.
3
This column presents the percentage change
from GAAP revenue for the three and nine months ended September 30,
2022 to non-GAAP revenue for the three and nine months ended
September 30, 2023 (as recalculated using the foreign currency
exchange rates in effect during the three and nine months ended
September 30, 2022) in order to provide a constant-currency
comparison.
Proto Labs, Inc.
Product Developer
Information
(Unaudited)
Three months ended September
30,
Nine months ended September
30,
2023
2022
2023
2022
Unique product developers and engineers
served
23,080
23,816
45,668
47,793
View source
version on businesswire.com: https://www.businesswire.com/news/home/20231103037185/en/
Investor Relations Contact Protolabs Ryan Johnsrud,
612-225-4873 Manager – Investor Relations and FP&A
ryan.johnsrud@protolabs.com Media Contact Protolabs Brent
Renneke, 763-479-7704 PR & Media Strategist
brent.renneke@protolabs.com
Proto Labs (NYSE:PRLB)
Historical Stock Chart
From Apr 2024 to May 2024
Proto Labs (NYSE:PRLB)
Historical Stock Chart
From May 2023 to May 2024